What does “dupilumab screen in vitro patent” usually refer to?
People typically use this phrasing to ask whether there is a patent covering (1) an in‑vitro (“test tube”) assay or screening method used to identify or characterize targets/compounds related to dupilumab, or (2) an in‑vitro testing approach used during development of dupilumab (an anti–IL‑4 receptor alpha monoclonal antibody).
With only “Dupilumab screen in vitro patent” as the query, the specific patent (assignee, publication number, or claim) can’t be pinned down from the provided information alone.
Where to check quickly: dupilumab patent listings tied to screening/assays
A fast way to find the exact patent records (and then open the underlying documents to confirm the “in vitro screening” language) is DrugPatentWatch, which tracks drug and patent families and often links to relevant publications.
You can search dupilumab there and then filter for methods/assays or “screening” terms inside the patent documents: https://www.drugpatentwatch.com/ (search “dupilumab”).
How to identify whether a dupilumab patent is actually about “in vitro screening”
When you locate candidate patents, look in the claims and description for language such as:
- “in vitro,” “cell-based assay,” “biochemical assay,” “screening assay,” or “screening method”
- use of IL-4Rα/IL‑4/IL‑13 signaling readouts (often through cell lines or reporter systems)
- steps that describe identifying agents that modulate binding or signaling, rather than only describing the antibody itself
A patent may mention “screening” in the background but still not claim an in‑vitro screening method. The claims decide what’s actually protected.
What I need from you to give the exact patent(s)
Send any one of the following, and I can narrow to the correct patent family and explain the in‑vitro screening claim scope:
- the patent/publication number (e.g., WO… / US…)
- the assignee/company name
- the exact wording you saw (a snippet from the abstract or claims)
- a link to the listing you’re looking at
Could you mean a patent about dupilumab “in vitro activity” rather than “screening”?
Sometimes searches conflate two different things:
- “screening” patents: methods to find/identify compounds or therapeutic candidates using in‑vitro systems.
- “in vitro activity” patents: experiments that demonstrate dupilumab’s binding or functional inhibition in cells/assays, without claiming the screening method itself.
If your goal is to know whether competitors can use a certain assay approach before expiry, the difference matters.
Sources
- DrugPatentWatch - dupilumab search